Skip to main content
. 2007 Jun 15;62(12):1095–1101. doi: 10.1136/thx.2006.069963

Table 1 Main characteristics and functional variables of study subjects.

Controls (n = 6) Patients with OSAS before treatment (n = 12) Patients with OSAS after treatment (n = 12)
Age (years) 43.5 (13) 43 (10) 43 (11)
BMI (kg/m2) 33.9 (6.2) 35.9 (8) 34.3 (6)
AHI (events/h) 4 (1.5) 78 (41.2)*** 3 (3.8)†††
Mean Sao2 (%) 95 (3.5) 85 (7.5)*** 94 (4)†††
Nadir Sao2 (%) 92 (5) 70 (26.5)*** 88 (5)†††
Time Sao2 <90% (%) 1 (3.5) 74 (22.5)*** 1 (15)†††
CPAP (cm H2O) 9 (3.5)
CPAP time (h) 5 (1.2)
ESS score 5.5 (5.2) 16 (5.5)*** 9.5 (7.2)†††
FEV1 (% pred) 93 (28) 95 (11) 99 (12)
FVC (% pred) 93 (24) 111 (20) 111 (15)
FEV1/FVC (%) 80 (6) 75 (7) 73 (3)
FRC (% pred) NA 87 (19) 96 (20)
Tlco (% pred) NA 118 (36) 125 (41)
Pao2 (mm Hg) 74 (8) 74 (15) 78 (12)
Paco2 (mm Hg) 40.1 (5) 41.5 (3.1) 39.6 (2.9)
MIP (% pred) N.A. 91 (21) 108 (33)
Tlim (min) 9.5 (1.6) 3.2 (4.3)*** 2.1 (0.2)
Handgrip, (% pred) NA 115 (69) 131 (72)
6‐min walking distance (% pred) NA 92 (13) 90 (19)
Type I fibres (%) 48 (11) 57 (15)* 41 (27)††
Type II fibres (%) 52 (11) 43 (15)* 59 (27)††
Type I fibre area (μm2) 1813 (1018) 2206 (585) 1970 (266)
Type II fibre area (μm2) 2219 (1005) 2206 (1079) 2463 (633)

Data are presented as median (interquartile range).

BMI, body mass index; Sao2, arterial oxygen saturation; CPAP, continuous positive airway pressure; ESS, Epworth Sleepiness scale; FEV1, forced expiratory volume in 1 s; pred, predicted; FVC, forced vital capacity; FRC, functional residual capacity (as expressed by intrathoracic gas volume); Tlco, carbon monoxide transfer factor; MIP, maximal inspiratory pressure, Tlim, endurance time.

*p⩽0.05, **p⩽0.01, ***p⩽0.001 control subjects vs OSAS patients before treatment.

†p⩽0.05, ††p⩽0.01, †††p⩽0.001 OSAS patients before vs after treatment.